from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1182/papA3

LFCtreatmentdescriptionclass of inhibitor

-1.631

Amikacinug/mL Amikacintranslation

-2.159

Cap5-10ug/mL Capreomycintranslation

-2.225

Rox10-50 ug/mL Roxithromycintranslation

-1.534

SM2-5 ug/mL Streptomycintranslation

-1.836

Tet5-10 ug/mL Tetracyclinetranslation

0.166

Rif0.2-5ug/mL Rifampicintranscription

-0.705

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.221

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.399

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.567

CPZ10-50 ug/mL Chlorpromazinerespiration

0.177

Clofazimine10-13 ug/mL Clofaziminerespiration

0.599

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.934

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.222

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.859

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.607

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.860

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.351

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.188

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.119

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.118

KCN5-20 ug/mL Potassium cyaniderespiration

0.305

NaN30.2-2 mM Sodium aziderespiration

0.709

Nigericin50 uM Nigericinrespiration

-0.708

TRC10-150 ug/mL Triclosanrespiration

-0.621

TRZ10-25 ug/mL Thioridazinerespiration

-1.248

Valinomycin0.5-10 uM Valinomycinrespiration

1.109

ZnSO42 mM ZnSO4respiration

-0.709

menadione6-10 ug/mL Menadionerespiration

0.419

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.164

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.678

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.401

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.090

NRP_1Non-replicating persistence stage 1dosRassociated

0.291

Amp0.2mg/mL AmpicillincellWall

0.250

Cephalexin20-100 ug/mL CephalexincellWall

-0.277

Cerulenin0.32-5 ug/mL CerulenincellWall

0.815

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.515

EMB10-20 ug/mL EthambutolcellWall

0.037

Eta12-40 ug/mL EthionamidecellWall

-0.378

INH0.2-0.4 ug/mL IsoniazidcellWall

1.408

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.475

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.115

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.557

BZA0.12 mg/mL BenzamidearomaticAmides

-0.484

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.633

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.390

H2O24 mM hydrogen peroxideDNAdamaging

-0.274

Levo10 ug/mL LevofloxacinDNAdamaging

0.172

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.881

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.945

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.307

UVUV-irradiationDNAdamaging

-1.403

ARP41-4 ug/mL Antitubercular compound ARP4?

0.728

Antimycin12.5-50 ug/mL Antimycin A?

0.362

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.441

PA_110-50 ug/mL Antitubercular compound PA-1?

0.587

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.871

PA8240.2-2 ug/mL PA-824?

-1.477

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.195

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.570

Verapamil50 uM Verapamil?

0.766

mercaptoethanol2 mM 2-Mercaptoethanol?

0.248

methoxatin10-20 ug/mL Methoxatin?